Pinnacle Wealth Management Advisory Group LLC decreased its position in The Cigna Group (NYSE:CI – Free Report) by 3.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,588 shares of the health services provider’s stock after selling 49 shares during the period. Pinnacle Wealth Management Advisory Group LLC’s holdings in The Cigna Group were worth $439,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also added to or reduced their stakes in the company. McClarren Financial Advisors Inc. boosted its holdings in shares of The Cigna Group by 4.7% in the 3rd quarter. McClarren Financial Advisors Inc. now owns 692 shares of the health services provider’s stock valued at $240,000 after acquiring an additional 31 shares during the last quarter. Adero Partners LLC grew its position in The Cigna Group by 4.5% during the 3rd quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock worth $273,000 after purchasing an additional 34 shares during the period. Waldron Private Wealth LLC raised its stake in shares of The Cigna Group by 1.0% during the 3rd quarter. Waldron Private Wealth LLC now owns 3,651 shares of the health services provider’s stock valued at $1,265,000 after buying an additional 35 shares during the last quarter. CreativeOne Wealth LLC lifted its holdings in shares of The Cigna Group by 3.0% in the 3rd quarter. CreativeOne Wealth LLC now owns 1,219 shares of the health services provider’s stock valued at $422,000 after buying an additional 35 shares during the period. Finally, Smithfield Trust Co lifted its holdings in shares of The Cigna Group by 3.6% in the 3rd quarter. Smithfield Trust Co now owns 1,080 shares of the health services provider’s stock valued at $373,000 after buying an additional 38 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.
The Cigna Group Stock Performance
NYSE CI opened at $292.12 on Monday. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The firm has a market capitalization of $81.25 billion, a P/E ratio of 23.87, a price-to-earnings-growth ratio of 0.94 and a beta of 0.54. The stock’s fifty day moving average is $286.46 and its two-hundred day moving average is $320.86. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66.
The Cigna Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.07%. The Cigna Group’s dividend payout ratio is currently 45.75%.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on CI. Oppenheimer reduced their price target on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research report on Friday, January 31st. Sanford C. Bernstein downgraded shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target on the stock. in a report on Thursday, February 6th. Cantor Fitzgerald decreased their price objective on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Truist Financial cut their price target on The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research note on Tuesday, February 4th. Finally, Piper Sandler reissued an “overweight” rating and issued a $348.00 price objective (down from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $373.69.
Check Out Our Latest Report on The Cigna Group
The Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than The Cigna Group
- Investing In Automotive Stocks
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Canadian Penny Stocks: Can They Make You Rich?
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- How to Calculate Options Profits
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.